Share this article
Share this article
NEW BRUNSWICK, N.J., Jan. 26, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic, said Alex Gorsky, Chairman and Chief Executive Officer. I m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs. These efforts, and our commitment to families around the world as the largest broad-based healthcare company, enabled us to lead in the fight against COVID-19. We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon. Johnson & Johnson was built for times like these, and I am extremely confident in our ability to deliver lasting value and continued innovat